Intravenous (IV) propofol was compared with IV thiopental/pentobarbital as a sedative for children undergoing magnetic resonance imaging (MRI) of the brain or spine. Fifty-eight outpatients (aged 11 mo to 6% yr, ASA grade I and 11) were enrolled in the study and randomized to two groups. After IV cannulation, Group I received IV propofol (1-2 mg/kg), followed immediately by a propofol infusion (75-100 pg.kg-'.min-'). Group I1 received IV thiopental (1-3 mg/kg) followed by a pentobarbital bolus (2-3 mg/kg). Supplemental thiopental doses (1) (2) mg/kg) were administrated to maintain adequate sedation. Discharge time and postanesthesia recovery scores were determined by an independent blinded observer. Time of recovery to full consciousness in Group I was significantly less than in Group I1 (19 2 7min vs 35 ? 20; P < 0.005). Time to discharge was also significantly less in Group I (24 ? 6 min vs 40 ? 11; P < 0.05). A preliminary cost analysis was applied to the clinical data obtained and to a theoretical model of a pediatric MRI center. Cost analysis of anesthesia services revealed added drug costs ($1600.76 per year for the propofol group) but significant savings of postanesthesia care unit (PACU) nursing time ($5086.67 per year). Outcomes such as patient morbidity and technical quality of the MRI scans did not differ significantly between the two groups. In conclusion, analysis of the clinical data suggests that propofol may be more suitable than barbiturates for children undergoing outpatient procedures despite its higher price.
(Anesth Analg 1994;79:1102-6) hiopental/pentobarbital intravenous (IV) bolus administration has been used in our institution T for several years in more than 1000 children undergoing magnetic resonance imaging (MRI) (1) .
Although this technique has been proven safe and effective, the duration of sedation and recovery may be unpredictable. Propofol has recently become popular for IV sedation in outpatient procedures because of the rapid recovery associated with its use (1) (2) (3) . Although several reports indicate that propofol can be used safely for children undergoing MRI (1, 3) , the cost of propofol is much greater than that of other IV sedatives. Before a new and more expensive drug can replace an existing drug, cost-effectiveness should be demonstrated (4) . The purpose of this preliminary investigation, therefore, was to compare the recovery time, cost, and outcomes of IV administered propofol versus barbiturates by an anesthesiologist for children undergoing outpatient MRI. 
Methods
After obtaining institutional review board approval and informed consent from the parents, 58 children aged 11 mo to 6% yr were enrolled in the study. The subjects were outpatients, ASA grades I and 11, who were scheduled for elective MRI scan. No patient received preanesthetic medication.
Subjects were randomly assigned to one of two treatment groups to receive either propofol (Diprivanm; Stuart, Wilmington, DE) or thiopental (PentothaP; Abbott Laboratories, Chicago, IL) and pentobarbital (NembutaP; Abbott Laboratories). Group I received an IV propofol loading dose (1-2 mg/kg) which was titrated to effect. This was followed immediately by an IV propofol infusion (75-100 pg-kg-l-min-l) titrated to prevent patient's movement. Group I1 received IV thio- monitored throughout the scan. A noninvasive MRIcompatible blood pressure monitor and electrocardiogram were available and monitored intermittently. An anesthesiologist monitored the child continuously via a video camera from the MRI control room, and entered the scanner room as needed.
Discharge time, time intervals from the end of the MRI scan to the time of individual recovery endpoints, and total recovery score (0 to 7) after 5 and 10 min were determined. Recovery variables were modified from the method of Steward (5) and included consciousness, airway patency, and motor activity. Recovery scores and time intervals were determined by an independent, trained, blinded observer. Parents were asked to record vomiting episodes at home, and an investigator contacted the parents the following day. Amount of drug administered, desaturation episodes (Spo, c 90%), incidence of vomiting, and occurrence of other adverse effects were recorded. All MRI scans were reviewed retrospectively by a "blinded" radiologist who graded the quality of the scans specifically looking for fine motion artifacts (scale of 1 to 10, where 1 = unreadable, must be repeated, and 10 = perfect technical quality).
Data are expressed as mean ? SD. Recovery times were analyzed using the Mann-Whitney U-test, and recovery scores were examined using the Mann-Whitney rank sum test. Because the data did not show a normal distribution, nonparametric analysis was used where appropriate. Pearson's linear regression analysis was performed to determine the impact of cumulative drug dose on recovery time. Occurrence of adverse effects in both groups was compared using the 2 test. Statistical significance was assumed for P < 0.05.
Based on data from 45 centers with the most experience in MRI, a pediatric MRI model was assembled (6) . This model operates 5.6 days/wk, and has 12 procedures scheduled per day. Assuming most pediatric MRI centers use anesthesia services only 1 day/wk, calculations are based on a total of 52 days/yr. Thus, this preliminary cost analysis is based on 629 children per year with the following procedures: brain MRI 73%, spine MRI 22%, and extremity MRI of 5% (see Appendix) (7) .
Results
The two groups of children did not differ significantly with regard to demographic characteristics or type of MRI (brain or spine). The mean loading dose was 1.7 ? 0.4 mg/kg (mean ? SD) for propofol, 2.2 +-0.5 mg/kg for thiopental, and 2.1 t 0.4 mg/kg for pentobarbital. Mean infusion dose for propofol was 90 ? 27 pg.kg-'.min-l and thiopental doses per patient averaged 6.1 -t_ 3.2 mg.kg-'.h-'. Linear regression analysis, performed to determine the impact of cumulative drug dose on recovery time, revealed a nonsignificant regression coefficient in both treatment groups (v < 0.3 in all analyses).
Spontaneous respiration was maintained in all patients and no ventilatory support was required. The incidence of oxygen desaturation did not differ significantly between the two groups (barbiturates 4% versus propofol 5%, not significant), and all desaturation resolved spontaneously (71% propofol vs 74% barbiturates) or responded immediately to repositioning the head. The incidence of vomiting over the first 24 h was the same in both groups (8% vs 7%, not significant).
Time of recovery to full consciousness (Steward score 7) in Group I (propofol) was significantly less than in Group I1 (barbiturates) (19 * 7 min vs 35 ? 20; P < 0.005). Airway and motor recovery times were also significantly less in Group I (Figure 1 ). In addition, time to home discharge was significantly shorter in the propofol-treated group among all types of MRI procedures.
Theoretical nonquantitative cost analysis revealed no difference in the direct or indirect costs of the radiology department. In contrast, analysis of anesthesia drugs revealed an added yearly drug cost of $1600.76 for the propofol group (see Appendix). The shorter recovery time in the propofol group amounted to savings of 187.7 subject recovery hours per year or $5086.67 (see Appendix). Overall cost analysis reveals a yearly savings of $3227.91 ($5086.67 nursing time saved [C2] -$1600.76 added drug cost [Cll). Other anesthesia-related direct and indirect costs, such as anesthesiology staff time, equipment, and supplies, were assumed to be the same between the two groups.
Both the clinical outcome and the incidence of morbidity such as desaturation and vomiting was similar in both groups (E, or health effects are unchanged). Direct benefits (Bl, radiologic outcome) include also a better technical quality of the MRI scans, and although the average MRI "quality score" for the propofol group was higher (9.0 2 1.3 vs 8.3 2 1.9) this did not achieve statistical significance. No scan was of such poor quality that it had to be repeated.
Although parents of children in the propofol group spent less time with their child in the postanesthesia care unit (PACU) (187.7 h/yr/parent) and could return to productive activity more rapidly, it is reasonable to assume that most parents will take a day off work and not take advantage of the saved time (B2 = no difference).
Discussion
This study demonstrates that, although both IV propofol and barbiturates can be used safely in children 
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undergoing MRI, propofol is associated with significantly shorter recovery and discharge times. Cost analysis of anesthesia services revealed added drug costs and significant savings of PACU nursing time.
Both the clinical outcome and the radiologic outcome were similar in both groups. Several recent editorials and reviews emphasize the importance of cost effectiveness assessment in anesthesia (8 -10) . This approach is especially important considering the fact that anesthesia providers control 3%-5% of the annual total health care costs in the United States, approximately $9 billion for provider services and $11.7 billion for preoperative tests (10) . However, cost effectiveness assessment has not been widely accepted in the anesthesia community, and most anesthesia-related investigations ignore cost analysis (1 1). Johnstone and Martinec (10) reported that, in a 1991 survey of anesthesia literature, only 2% of clinical investigations and 1 % of scientific abstracts included any useful cost information.
Three measures are used to assess cost and benefit in clinical trails (4, 7) . Cost benefit analysis involves a monetary estimate of the ratio of total costs to benefits. This approach, however, evaluates a new drug solely in financial terms and fails to consider clinical outcome or patient satisfaction. Cost effectiveness analysis, on the other hand, measures the benefits or outcomes in biologic terms as well. Even if a new drug is associated with additional costs, it may be the preferred regimen if it results in improved clinical outcome. Cost utility analysis examines outcome of different therapeutic regimens in units that also consider quality of life; for example, survival adjusted for quality of life. A preliminary cost analysis revealed that although propofol costs more, its use resulted in significantly less PACU nursing time. These savings are even more significant when one considers the many pediatric outpatient procedures for which propofol is suitable (radiation therapy, gastrointestinal endoscopy, transesophageal echocardiography, bronchoscopy, and dental procedures). Similar findings were reported by Sung et al. (12) , who compared the PACU profile of adult outpatients anesthetized with propofol/N,O versus thiopental/isoflurane. Recovery time was significantly less with propofol, and the investigators projected that in a 4000-case/yr facility, 1000 nursing hours would be saved.
There are several parties that could benefit from this reduction in PACU nursing costs. A significant reduction in PACU nursing time may directly translate to less expense per procedure for the hospital. In order for the hospitals to take advantage of this reduction in MRI recovery nursing time it is essential that they have the capability to move nurses between the various pediatric PACUs. If one group of recovery nurses staff all the PACUs including the MRI PACU, then the savings in nursing time in the MRI PACU might potentially be directly translated to working hours in other PACUs. It is unclear whether this reduction in hospital expense will ultimately be passed along in the form of lower charge per procedure to the third party payers.
The cost analysis used is not applicable for pediatric MRI centers that routinely use IV barbiturates without an anesthesiologist. If anesthesia services are needed when propofol is used, but not when barbiturates are administrated, total costs will be significantly increased even after adjusting for reduced PACU demands. A careful comprehensive cost effectiveness PEDIATRIC ANESTHESIA KAIN analysis examining clinical outcome (decreased morbidity and mortality) when an anesthesiologist is present might reveal an advantage to IV propofol use. Because of the low incidence of morbidity and mortality following the use of both barbiturates and propofol, such an analysis is difficult and would require a large number of subjects.
In conclusion, propofol sedation is associated with significantly shorter recovery time than thiopental/ pentobarbital sedation in pediatric MRI scans. A cost analysis suggests that propofol may be more suitable for children undergoing an outpatient procedure despite its higher price. A limitation of this preliminary study is that many of the anesthesia and radiologic costs were not quantified but were presumed to be the same for both groups. A more comprehensive cost effectiveness analysis that will examine the various costs detailed in Table 1 is still needed.
Appendix
where economic benefits are direct (B,) and indirect (BJ; costs are direct (C,) and indirect (CJ; and natural units, e.g., health effects (E). The total number of subjects in the model is 629; the types of MRI are brain 73%, spine 22%, extremity 5%; the average weight of the subjects is 14 kg; and the average imaging time is 45 min for brain, 79 min for spine, and 28 min for extremity. 
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